News&lnfo
RecBio is a high-tech enterprise jointly founded by the former vaccine R & D expert team from the Chinese Center for Disease Control and Prevention (China CDC) and the senior vaccine industrialization team.
The company has established a leading domestic R & D and innovation platform for new adjuvants, genetic engineering, and immune evaluation.

Further promote the implementation of IPD system to lay the foundation for a better future of RecBio - Written on the launch of the IPD Phase II

  • Categories:News & Info
  • Author:Li Bu
  • Origin:
  • Time of issue:2020-10-27
  • Views:0

(Summary description)Our company's ongoing development of the Integrated Product Development (IPD) system is a foundation for RecBio's great cause. IPD is an advanced, scientific and mature system of product development models, concepts and methods.

Further promote the implementation of IPD system to lay the foundation for a better future of RecBio - Written on the launch of the IPD Phase II

(Summary description)Our company's ongoing development of the Integrated Product Development (IPD) system is a foundation for RecBio's great cause. IPD is an advanced, scientific and mature system of product development models, concepts and methods.

  • Categories:News & Info
  • Author:Li Bu
  • Origin:
  • Time of issue:2020-10-27
  • Views:0
Information

Our company's ongoing implementation of the Integrated Product Development (IPD) system is a foundation for RecBio's great cause. IPD is an advanced, scientific and mature system of product development models, concepts and methods. More importantly, the implementation of IPD system is a comprehensive and profound management change to RecBio.

 

Since the launch of the IPD project in Beijing R&D center 4 months ago, the company has completed the planned task ahead of schedule. The IPD concept has been deeply rooted in employee’s mind, and the process overview (pocket card) has been completed. The PDT (Project Development Team) has been initially set up, and the trial run of the R&D project has been launched according to IPD. The IPD structure and process has been extended to the Taizhou industrialization team, and the implementation of the IPD project has entered the critical Phase II.

The main task of the Phase II of our IPD project is to promote the implementation of the IPD project throughout the company. First of all, we must realize the conceptual transformation from "responsible to people" to "responsible to tasks", establishing good working culture that puts the goal first, keeps an eye on plans, respects processes, and promotes open communication. Secondly, we should focus on the construction of micro-processes that facilitate the IPD operation and open up the "capillaries" of the IPD system. Finally, the working method should focus on fully exposing problems and should solve them in a timely manner. We should resolutely oppose the "flashlight culture" that only sheds the light at others but not ourselves, resolutely oppose "criticizing shortcomings all the time", and resolutely oppose "keeping silent during meetings while talking nonsense afterwards". We should give strong support and attention to promoting employees who undertake the responsibility and actively expose and solve problems in their work, while strictly assess those who do not take responsibility for their own safety, and seriously dealing with those who do not obey the IPD process.

 

The construction of IPD management system is a long-term project that cannot be accomplished overnight. It requires patience and careful planning for phased implementation and continuous improvement. Meanwhile, the company's key projects have stringent requirements on schedule and quality, and high demands for inter-departmental collaboration, which urgently calls for the support of the IPD system, while not allowing us to "slow down and look around before approving". In this context, only by combining training and learning with brave practice as well as learning and improving in practice, can we realize the coordinated development of R&D industrialization progress and management system construction, thus laying the foundation for building RecBio into a great vaccine enterprise.

Scan the QR code to read on your phone

  • TOP   

Contact Us

Jiangsu Rec-Biotechnology Co., Ltd.

tel:+86-523-86818860

 

Address: Vaccine Engineering Center, China Medical City, Taizhou

Copyright © 2020 Jiangsu Rec-Biotechnology Co., Ltd.  All rights reserved.      苏ICP备19043567号-1